Cas:58290-35-0 Boc-S-4-methoxybenzyl-D-cysteine manufacturer & supplier

We serve Chemical Name:Boc-S-4-methoxybenzyl-D-cysteine CAS:58290-35-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Boc-S-4-methoxybenzyl-D-cysteine

Chemical Name:Boc-S-4-methoxybenzyl-D-cysteine
CAS.NO:58290-35-0
Synonyms:Boc-Cys(pMeOBzl)-OH, Boc-Cys(Mob)-OH;Cysteine, N-[(1,1-dimethylethoxy)carbonyl]-S-[(4-methoxyphenyl)methyl]-;N-(Tert-Butoxycarbonyl)-S-(4-Methoxybenzyl)-D-Cysteine;S-(4-Methoxybenzyl)-N-{[(2-methyl-2-propanyl)oxy]carbonyl}cysteine
Molecular Formula:C16H23NO5S
Molecular Weight:341.422
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:514.0±50.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.547
PSA:110.16000
Exact Mass:341.129700
LogP:3.85

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Boc-Cys(pMeOBzl)-OH, Boc-Cys(Mob)-OH chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,S-(4-Methoxybenzyl)-N-{[(2-methyl-2-propanyl)oxy]carbonyl}cysteine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,S-(4-Methoxybenzyl)-N-{[(2-methyl-2-propanyl)oxy]carbonyl}cysteine Use and application,Boc-Cys(pMeOBzl)-OH, Boc-Cys(Mob)-OH technical grade,usp/ep/jp grade.


Related News: GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. phenyl (2S,3R)-2,3-epoxyheptanoate manufacturers The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. 4H-1,3-Oxazin-4-one,3-[2-(3,5-difluorophenyl)-2-hydroxy-1,1-dimethylethyl]-2,3-dihydro-6-methyl-5-phenyl- suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2,2-diacetoxy-3-(2-hydroxypropyl)-4-methyl-2H-2l4-benzo[e][1,3,2]oxazaborinin-3-ium vendor & factory.